We are live on ! Find out more
BCM

BlueCrest Capital Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 20.01%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+20.01%
3 Year Est. Return
+41.66%
5 Year Est. Return
+41.11%
10 Year Est. Return
+377.48%
AUM
$3.86B
AUM Growth
+$648M
Cap. Flow
+$522M
Cap. Flow %
13.54%
Top 10 Hldgs %
27.7%
Holding
2,121
New
678
Increased
371
Reduced
368
Closed
674

Sector Composition

Rank Sector Weight
1 Technology 10.14%
2 Industrials 8%
3 Healthcare 7.93%
4 Financials 7.7%
5 Energy 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
26
PUT
iShares Russell 2000 ETF
IWM
$80.4B
$16.4M 0.42%
+100,000
New +$16M
CXO
27
DELISTED
CONCHO RESOURCES INC.
CXO
$16M 0.41%
115,292
+73,423
+175% +$10.5M
CELG
28
DELISTED
Celgene Corp
CELG
$15.8M 0.41%
199,479
+108,263
+119% +$8.99M
PFE icon
29
Pfizer
PFE
$144B
$15.8M 0.41%
+459,132
New +$15.7M
QQQ icon
30
Invesco QQQ Trust
QQQ
$445B
$15.4M 0.4%
89,814
+66,239
+281% +$11.1M
AET
31
DELISTED
Aetna Inc
AET
$15.4M 0.4%
83,981
-32,516
-28% -$5.8M
PBR.A icon
32
Petrobras Class A
PBR.A
$104B
$15.3M 0.4%
+1,726,324
New +$19.6M
WTFC icon
33
Wintrust Financial
WTFC
$10.9B
$15M 0.39%
172,601
+163,050
+1,707% +$15M
GSAH.U
34
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
$14.9M 0.39%
+1,455,481
New +$14.9M
PRAH
35
DELISTED
PRA Health Sciences, Inc.
PRAH
$14.8M 0.38%
158,681
+153,756
+3,122% +$13.2M
STR
36
DELISTED
Sitio Royalties
STR
$14.8M 0.38%
+364,857
New +$14.5M
JPM icon
37
JPMorgan Chase
JPM
$948B
$14.3M 0.37%
137,169
+73,099
+114% +$8.02M
IWM icon
38
iShares Russell 2000 ETF
IWM
$80.4B
$13.9M 0.36%
+85,097
New +$13.6M
CSCO icon
39
Cisco
CSCO
$457B
$13.8M 0.36%
319,851
-94,971
-23% -$4.15M
CHE icon
40
Chemed
CHE
$6.83B
$13.6M 0.35%
42,331
+41,463
+4,777% +$13M
ICUI icon
41
ICU Medical
ICUI
$4.16B
$13.4M 0.35%
+45,689
New +$12.5M
EFA icon
42
CALL
iShares MSCI EAFE ETF
EFA
$76.8B
$13.4M 0.35%
200,000
-175,000
-47% -$12.3M
NXPI icon
43
CALL
NXP Semiconductors
NXPI
$65.9B
$13.1M 0.34%
+120,000
New +$13.2M
BKR icon
44
Baker Hughes
BKR
$57.9B
$12.8M 0.33%
387,392
+379,914
+5,080% +$12.9M
ROK icon
45
Rockwell Automation
ROK
$52.3B
$12.6M 0.33%
75,890
+65,585
+636% +$11.4M
IT icon
46
Gartner
IT
$10.4B
$12.2M 0.32%
92,079
+78,377
+572% +$10M
GD icon
47
General Dynamics
GD
$107B
$12.1M 0.31%
64,810
+57,259
+758% +$11.7M
EXAS
48
DELISTED
Exact Sciences
EXAS
$11.9M 0.31%
198,567
+188,283
+1,831% +$10.1M
GLW icon
49
Corning
GLW
$107B
$11.6M 0.3%
+422,565
New +$11.7M
IART icon
50
Integra LifeSciences
IART
$1.52B
$11.6M 0.3%
+179,670
New +$11.1M

Similar funds

BlueCrest Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, BlueCrest Capital Management held 2,121 positions worth $3.86B, up 20% from $3.21B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

BlueCrest Capital Management deployed $522M of net new capital in Q2 2018, opening 678 new positions and adding to 371 existing holdings. Its largest new stake was PepsiCo: 255,960 shares worth $27.9M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 6.3% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Nutrien, an estimated $42.4M trimmed.

  • BlueCrest Capital Management's largest Q2 2018 buy was PepsiCo: 255,960 shares worth $27.9M.
  • BlueCrest Capital Management added most to State Street Financial Select Sector SPDR ETF in Q2 2018, an estimated $91.2M increase.
  • BlueCrest Capital Management's biggest Q2 2018 reduction was Nutrien, cutting an estimated $42.4M.
  • BlueCrest Capital Management fully exited iShares MSCI Emerging Markets ETF in Q2 2018, selling an estimated $19.8M.
  • BlueCrest Capital Management's ten largest holdings make up 28% of its $3.86B portfolio in Q2 2018.
  • BlueCrest Capital Management opened 678 new positions and closed 674 in Q2 2018.
  • BlueCrest Capital Management's portfolio value rose 20% quarter-over-quarter to $3.86B.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.